Investors

Press Releases

Endonovo Therapeutics Provides Corporate Update and 2018 Outlook
Endonovo Therapeutics Engages ShareIntel, A Leader In Shareholder Intelligence Services To Investigate Market Maker and Clearing Firm Irregularities
Endonovo Therapeutics Provides Update on Acquisition of PEMF Assets, Clinical Pipeline and Pre-Clinical Study
Endonovo Therapeutics Acquires Assets of Electroceuticals Developer, Rio Grande Neurosciences, and Settles Lawsuit
Endonovo Receives Positive Results from Pre-Clinical Study of Non-Invasive Electroceutical
Endonovo Therapeutics Provides Update on Pre-Clinical Studies
Endonovo Therapeutics, Inc. and Kodiak Capital Group, LLC Announce Settlement and Dismissal of Lawsuit
Endonovo Therapeutics Issues Open Letter and Update to Its Shareholders
Endonovo Evaluating Therapeutic Potential of Non-Invasive Electroceutical for Treatment of Kidney Disease
Endonovo Evaluating Therapeutic Potential of Non-Invasive Electroceutical for Treatment of Non-Alcoholic Steatohepatitis (NASH)
RSS
Show All